Related Experiment Video
Updated: Jun 12, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods
1Department of Microbiology, Vaccine and Infectious Disease Institute (VIDI), University of Antwerp, Antwerp, Belgium. Katherine.loens@ua.ac.be
Abstract:
Because of the absence of well-standardized both in-house and FDA-approved commercially available diagnostic tests, the reliable diagnosis of respiratory infection due to Mycoplasma pneumoniae remains difficult. In addition, no formal external quality assessment schemes which would allow to conclude about the performance of M. pneumoniae diagnostic tests exist. In this review, the current state of knowledge of M. pneumoniae-associated respiratory infections in the context of epidemiological studies published during the past 5 years is discussed, with particular emphasis on the diagnostic strategies used and their impact on results. The role of M. pneumoniae as a cause of respiratory tract infections (RTIs) differs from study to study due to geographical and epidemiological differences, as well as to the application of different diagnostic techniques and criteria used.
Insights
Diagnosing respiratory infections caused by Mycoplasma pneumoniae is challenging due to a lack of standardized tests and quality assessments. This review examines diagnostic strategies and their impact on understanding M. pneumoniae
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Diagnostic Science
Background:
- Mycoplasma pneumoniae is a significant cause of respiratory tract infections (RTIs).
- Reliable diagnosis is hindered by the absence of standardized in-house and FDA-approved commercial diagnostic tests.
- No formal external quality assessment schemes exist for M. pneumoniae diagnostic tests.
Purpose of the Study:
- To review the current knowledge on M. pneumoniae-associated respiratory infections.
- To emphasize diagnostic strategies and their impact on study results.
- To discuss epidemiological studies from the past five years.
Main Methods:
- Literature review of epidemiological studies published in the last 5 years.
- Analysis of diagnostic strategies employed in these studies.
- Evaluation of the impact of diagnostic methods on reported M. pneumoniae prevalence.
Main Results:
- The role of M. pneumoniae in RTIs varies across studies due to geographical and epidemiological factors.
- Inconsistent diagnostic techniques and criteria contribute to differing results.
- Lack of standardized testing impacts the comparability of M. pneumoniae prevalence data.
Conclusions:
- The diagnosis of Mycoplasma pneumoniae respiratory infections remains challenging.
- Variability in diagnostic approaches affects the understanding of M. pneumoniae's epidemiological role.
- Standardization of diagnostic tests and implementation of quality assessments are crucial.
Related Concept Videos
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rapid Identification of Pathogens
